# A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy

> **NCT01285219** · PHASE3 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 337 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** pegylated filgrastim and filgrastim
- **DRUG:** filgrastim and pegylated filgrastim

## Key facts

- **NCT ID:** NCT01285219
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-05
- **Final completion:** 2008-12
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2011-01-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285219, "A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01285219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*